Validation of novel diagnostic marker of lung adenocarcinoma by using detection of urinary protein fragment: a multicenter study

Not Applicable

• Conditions: ung adenocarcinoma

• Registration Number: JPRN-UMIN000030956
• Lead Sponsor: niversity of Miyazaki

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-02-01
• Study Completion: 2020-03-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up continuing
• Sex: All
• Target Recruitment: 190

Inclusion Criteria

Not provided

Exclusion Criteria

Patients with lung adenocarcinoma 1.Patients who received treatment for lung adenocarcinoma 2. Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 3.Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 4.Patients who have current malignant neoplasm other than lung adenocarcinoma, or past history of malignant neoplasm within 5 years. 5.patients who were diagnosed with other types of lung cancer (not lung adenocarcinoma) 6.Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 7.Patients who is pregnant or who is suspected to be pregnant. 8.Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 9.Patients whose attending physicians consider to be inappropriate for this study. Patients with COPD 1.Patients who have proteinuria, positive urine sugar or urine occult blood in urinalysis. 2.Patients who have current malignant neoplasm other than lung squamous cell carcinoma, or past history of malignant neoplasm within 5 years. 3.Patients who have alcohol or drug dependence or who are suspected to have alcohol or drug dependence. 4.Patients who is pregnant or who is suspected to be pregnant. 5.Patients who was enrolled another clinical trial and was prescribed a study drug within one month. 6.Patients who were clinicaly suspected lung cancer by high resolution CT within 3 months. 7.Patients who have renal dysfunction (Serum levels of creatinine > 2.0 mg/dl). 8.Patients whose attending physicians consider to be inappropriate for this study. Healthy controls 1-5. Same criterias as COPD (1-5.) 6.Those who are current smokers or ex-smokers. 7.Those whose attending physicians consider to be inappropriate for this study.

Study & Design

• Study Type: Observational
• Study Design: Not specified